Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postpartum anemia: ferrous fumarate versus ferrous fumarate plus folic acid
NL-OMON32195Active, not recruiting
- Sponsor
- TweeSteden Ziekenhuis
- Start
- Mar 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ferrous fumarate and folic acid in postpartum anemia (3 arms), sponsored by TweeSteden Ziekenhuis. Primary endpoint: Increase in hemoglobin at 4 weeks postpartum. Started Mar 2008; status: active, not recruiting.
02
Drugs
ferrous fumaratefolic acid
03
Conditions
postpartum anemia
Beyond the preview
Go deeper on NL-OMON32195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32195.